Certified by Founder Lodge
Aro Biotherapeutics
United States - Philadelphia, Pennsylvania
START UP
1 Disclosed Funding Rounds $41,500,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Unlocking the Potential of Genetic Medicines
Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a pl
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 29 ,2023 | Series B | $41,500,000 |
Northpond Ventures
HealthCap
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
AIRRIVED | $6,100,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
